Rob Aboud
General Counsel at Affinia Therapeutics, Inc.
Profile
Rob Aboud is currently the Chief Legal Officer at Affinia Therapeutics, Inc. Prior to this, he worked as Of Counsel & Principal at Faber Daeufer Itrato & Cabot PC from 2013 to 2019.
Mr. Aboud has an undergraduate degree from Albright College and graduate degrees from Rutgers State University of New Jersey and Temple University (Pennsylvania).
Rob Aboud active positions
Companies | Position | Start |
---|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | General Counsel | 2019-07-31 |
Former positions of Rob Aboud
Companies | Position | End |
---|---|---|
Faber Daeufer Itrato & Cabot PC
Faber Daeufer Itrato & Cabot PC Miscellaneous Commercial ServicesCommercial Services Faber Daeufer Itrato & Cabot PC is an American company that provides legal services. | Corporate Officer/Principal | 2019-07-31 |
Training of Rob Aboud
Albright College | Undergraduate Degree |
Rutgers State University of New Jersey | Graduate Degree |
Temple University (Pennsylvania) | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Faber Daeufer Itrato & Cabot PC
Faber Daeufer Itrato & Cabot PC Miscellaneous Commercial ServicesCommercial Services Faber Daeufer Itrato & Cabot PC is an American company that provides legal services. | Commercial Services |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Rob Aboud